Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Yee

Showing results (131-140 of 188) with videos related to

Pageof 19
Sort By:
Cancer Cell|June 15, 2004
Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cellsSvetlana Avdulov, Shunan Li, Van Michalek, et al.
The Journal of Clinical Investigation|June 24, 2008
Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteinsMarta Guix, Anthony C Faber, Shizhen Emily Wang, et al.
Frontiers in Oncology|August 8, 2025
Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY TrialMark Hensley, Justin Lengfeld, Steven Stoesz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2025
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast CancerEmmanuel F Petricoin, Denise M Wolf, Christina Yau, et al.
Radiology|November 2, 2004
Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 TSina Meisamy, Patrick J Bolan, Eva H Baker, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2007
Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor systemMark N Kirstein, Richard C Brundage, Megan M Moore, et al.
Plos Genetics|November 30, 2023
Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancerMichael A Carpenter, Nuri A Temiz, Mahmoud A Ibrahim, et al.
Endocrinology|March 18, 2021
Leveraging Antiprogestins in the Treatment of Metastatic Breast CancerSailaja Kamaraju, Amy M Fowler, Elizabeth Weil, et al.
Plos One|March 19, 2016
Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast CancerMarc A Becker, Yasir H Ibrahim, Annabell S Oh, et al.
Frontiers in Oncology|June 29, 2023
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypesKatharine Yu, Amrita Basu, Christina Yau, et al.
Pageof 19

Showing results (131-140 of 188) with videos related to

Sort By:
Pageof 19
Cancer Cell|June 15, 2004
Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cellsSvetlana Avdulov, Shunan Li, Van Michalek, et al.
The Journal of Clinical Investigation|June 24, 2008
Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteinsMarta Guix, Anthony C Faber, Shizhen Emily Wang, et al.
Frontiers in Oncology|August 8, 2025
Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY TrialMark Hensley, Justin Lengfeld, Steven Stoesz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2025
Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast CancerEmmanuel F Petricoin, Denise M Wolf, Christina Yau, et al.
Radiology|November 2, 2004
Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 TSina Meisamy, Patrick J Bolan, Eva H Baker, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2007
Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor systemMark N Kirstein, Richard C Brundage, Megan M Moore, et al.
Plos Genetics|November 30, 2023
Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancerMichael A Carpenter, Nuri A Temiz, Mahmoud A Ibrahim, et al.
Endocrinology|March 18, 2021
Leveraging Antiprogestins in the Treatment of Metastatic Breast CancerSailaja Kamaraju, Amy M Fowler, Elizabeth Weil, et al.
Plos One|March 19, 2016
Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast CancerMarc A Becker, Yasir H Ibrahim, Annabell S Oh, et al.
Frontiers in Oncology|June 29, 2023
Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypesKatharine Yu, Amrita Basu, Christina Yau, et al.
Pageof 19